These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
720 related items for PubMed ID: 9296274
21. Nilvadipine in hypertension--experience in ambulatory treatment. Hoffmann A, Kraul H, Burkardt I. Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874 [Abstract] [Full Text] [Related]
22. Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women. Nordby G, Moan A, Kjeldsen SE, Os I. Am J Hypertens; 1995 May; 8(5 Pt 1):439-44. PubMed ID: 7662218 [Abstract] [Full Text] [Related]
23. Reduction in blood viscosity by treatment with coenzyme Q10 in patients with ischemic heart disease. Kato T, Yoneda S, Kako T, Koketsu M, Hayano I, Fujinami T. Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):123-6. PubMed ID: 2318549 [Abstract] [Full Text] [Related]
24. Blood rheology as a marker of venous hypertension in patients with venous disease. Khodabandehlou T, Boisseau MR, Le Dévéhat C. Clin Hemorheol Microcirc; 2004 Mar; 30(3-4):307-12. PubMed ID: 15258359 [Abstract] [Full Text] [Related]
32. Pentoxifylline attenuates the increase in whole blood viscosity after transfusion. Bacher A, Eggensperger E, Koppensteiner R, Mayer N, Klimscha W. Acta Anaesthesiol Scand; 2005 Jan; 49(1):41-6. PubMed ID: 15675980 [Abstract] [Full Text] [Related]
33. [Effect of nilvadipine on diurnal blood pressure profile. Use of a new calcium channel blocker in mild to intermediate hypertension]. Keck M, Quitzdorff G. Fortschr Med; 1992 Aug 30; 110(24):444-6. PubMed ID: 1398392 [Abstract] [Full Text] [Related]
34. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M. Nutr Metab Cardiovasc Dis; 2006 Mar 30; 16(2):137-47. PubMed ID: 16487914 [Abstract] [Full Text] [Related]
35. Detection of red cell aggregation by low shear rate viscometry in whole blood with elevated plasma viscosity. Janzen J, Elliott TG, Carter CJ, Brooks DE. Biorheology; 2000 Mar 30; 37(3):225-37. PubMed ID: 11026942 [Abstract] [Full Text] [Related]
36. Hemorheological disturbances and characteristic parameters in patients with cerebrovascular disease. Antonova N, Velcheva I. Clin Hemorheol Microcirc; 1999 Mar 30; 21(3-4):405-8. PubMed ID: 10711777 [Abstract] [Full Text] [Related]
39. Erythrocyte sodium cannot predict hypotensive effects of calcium channel blockers. Oshima T, Matsuura H, Ozono R, Ishida-Kainouchi M, Ishida T, Ishibashi K, Watanabe M, Okura Y, Kanbe M, Kajiyama G. Nihon Jinzo Gakkai Shi; 1993 Nov 30; 35(11):1227-31. PubMed ID: 8139134 [Abstract] [Full Text] [Related]
40. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients]. Szapáry L, Szóts M, Horváth B, Márton Z, Alexy T, Késmárky G, Juricskay I, Nagy F, Gaál V, Pálfi A, Koltai K, Tóth K. Orv Hetil; 2003 Jun 01; 144(22):1085-90. PubMed ID: 12847818 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]